je.st
news
Tag: congress
Best Project, Cultural: Dakar International Congress Center
2015-09-04 03:56:43| ENR.com: Headline News
Dakar International Congress Center Called a Tremendous Achievement. SUMMAs team overcame stiff challenges to design and build the project in only one year.
Tags: international
center
project
cultural
Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015
2015-09-03 12:31:15| Industrial Newsroom - All News for Today
Insights-driven approach seamlessly connects people, technologies and care protocols across the health continuum improving outcomes and the cost of healthcare delivery ANDOVER, Massachusetts and LONDON - Royal Philips (NYSE: PHG AEX: PHIA) today announced its presence at ESC Congress 2015, where the company is...
Tags: solutions
advance
procedures
integrated
Solid Waste Industry Seeks to Quash TRASH Act in Congress
2015-08-28 09:15:00| Waste Age
U.S. Sen. Bob Casey of Pennsylvania is eager for his home states landfills to be greener, cleaner and leaner by shedding tons of out-of-state garbage. But the diet the Democrat devised earlier this month via federal legislation doesnt pass the refuse industrys sniff test. read more
Tags: industry
act
solid
waste
Bristol-Myers Squibb and Pfizer to Present New Data on Eliquis (apixaban) at the ESC Congress 2015
2015-08-24 22:52:31| Biotech - Topix.net
Bristol-Myers Squibb Company and Pfizer Inc. announced today that 22 abstracts will be presented at the Congress 2015, to be held August 29 to September 2 in London, United Kingdom. The new data reinforce the Alliance's commitment to the ongoing evaluation of Eliquis in both the nonvalvular atrial fibrillation and venous thromboembolism patient populations.
Tags: the
data
present
congress
New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA (sitagliptin) Will Be Presented at the European Society of Cardiology Congress
2015-08-20 14:30:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. Additional Real-World Analyses from DYSIS and DYSIS II Assessing the Treatment of Dyslipidemia to be Presented KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today that new analyses from the investigational IMPROVE-IT (IMProved Reduction of Outcomes: VYTORIN Efficacy International Trial) study of VYTORIN (ezetimibe and simvastatin), the TECOS (Trial Evaluating Cardiovascular Outcomes with Sitagliptin) cardiovascular safety trial of JANUVIA (sitagliptin), and real-world data from the Dyslipidemia International Study (DYSIS I and DYSIS II) will be presented at the upcoming European Socie Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558orKim Hamilton, 908-391-0131orInvestor:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Sites : [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] next »